STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Activity
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

35 hedge funds and large institutions have $385K invested in Statera Biopharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.

Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
8
Closed
2
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$3K

Top Buyers

1
VF
1
Virtu Financial
New York
$13K
2
UBS Group
2
UBS Group
Switzerland
$13K
3
TSS
3
Two Sigma Securities
New York
$13K
4
Osaic Holdings
4
Osaic Holdings
Arizona
$2K
5
TRCT
5
Tower Research Capital (TRC)
New York
$4K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$176K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$2K
3
Jane Street
3
Jane Street
New York
$0
4
BPA
4
Beacon Pointe Advisors
California
$0
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$49K
Name Holding Trade Value Shares
Change 		Shares
Change %
AIC
26
Archer Investment Corporation
Indiana
$39 – – –
Jane Street
27
Jane Street
New York
– -$10K -35,422 Closed
BPA
28
Beacon Pointe Advisors
California
– -$5K -18,494 Closed
1
2